Lebenthal Global Advisors, LLC
- SEC CIK
- 0001845766
- Latest filing
- Jul 30, 2026
The latest 13F from Lebenthal Global Advisors, LLC covers Q2 2026 (filed Jul 30, 2026): 204 long positions worth $741.5M. The top 10 holdings make up 40.9% of the portfolio, and the largest is Fidelity Comwlth Tr at 7.4%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 30
- Est. +$35.3M
- Added
- 90
- Est. +$48.8M
- Reduced
- 80
- Est. −$102.1M
- Sold out
- 16
- Est. −$11.9M
Top 5 holdings
Share of this quarter's portfolio value
- Fidelity Comwlth Tr3159128087.4%$54.9M
- SPYSPDR S&P 500 ETF Trust
- Goldman Sachs ETF Tr3814301074.9%$36.3M
- JPMorgan Nasdaq Equity Premium Income ETF46654Q2034.4%$32.3M
- Vanguard Morningstar Value ETF9229087444.3%$31.8M
Biggest buys
New and added positions, by estimated amount bought
- Goldman Sachs ETF Tr381430107+$12.7MAdded
- Fidelity Merrimack STR Tr316188309+$9.53MAdded
- J P Morgan Exchange Traded F46641Q647+$7.19MAdded
- iShares Tr46434V878+$5.83MNew
- Invesco Exchange Traded FD T46137V597+$5.55MNew
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Goldman Sachs ETF Tr381430107+1.66 pp3.2% → 4.9%
- Fidelity Merrimack STR Tr316188309+1.24 pp0.6% → 1.9%
- J P Morgan Exchange Traded F46641Q647+0.80 pp2.8% → 3.6%
- iShares Tr46434V878+0.79 pp0.0% → 0.8%
- Invesco Exchange Traded FD T46137V597+0.75 pp0.0% → 0.7%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- J P Morgan Exchange Traded F46641Q332−$29.9MReduced
- SPYSPDR S&P 500 ETF Trust
- iShares Russell 1000 Growth ETF464287614−$12.1MReducedConverted for a 4-for-1 split
- Vanguard Scottsdale FDS92206C680−$9.61MReduced
- Vanguard Admiral FDS Inc921932885−$4.11MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- J P Morgan Exchange Traded F46641Q332−4.43 pp5.3% → 0.9%
- SPYSPDR S&P 500 ETF Trust
- iShares Russell 1000 Growth ETF464287614−1.41 pp2.8% → 1.4%
- Vanguard Scottsdale FDS92206C680−1.11 pp2.3% → 1.2%
- Vanguard Admiral FDS Inc921932885−0.48 pp1.3% → 0.9%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $741.5M
- +$53.7M (+7.8%) vs. prior quarter
- Positions
- 204
- +14 vs. prior quarter
- Top 10 concentration
- 40.9%
- Top 10 as share of value
- Turnover
- 11.8%
- Q2 2026, one quarter
- Average holding period
- 10.5 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $741.5M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | 204 | $741.5M | Fidelity Comwlth TrSPYGoldman Sachs ETF Tr | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 190 | $687.7M | SPYFidelity Comwlth TrJ P Morgan Exchange Traded F | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 28, 2026 | 180 | $647.9M | SPYFidelity Comwlth TrJ P Morgan Exchange Traded F | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 4, 2025 | 191 | $571.5M | J P Morgan Exchange Traded FSPYFidelity Comwlth Tr | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 187 | $535.6M | JPMorgan Nasdaq Equity Premium Income ETFJ P Morgan Exchange Traded FSPY | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 173 | $533.6M | SPYJPMorgan Nasdaq Equity Premium Income ETFJ P Morgan Exchange Traded F | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 22, 2025 | 189 | $547.5M | JPMorgan Nasdaq Equity Premium Income ETFJ P Morgan Exchange Traded FiShares Tr | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 28, 2024 | 181 | $492.6M | JPMorgan Nasdaq Equity Premium Income ETFJ P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 24, 2024 | 177 | $456.1M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFVanguard Morningstar Value ETF | vs. Q1 2024 | SEC |
| Q1 2024 | May 9, 2024 | 182 | $449.5M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFVanguard Morningstar Value ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 7, 2024 | 186 | $430.1M | J P Morgan Exchange Traded FVanguard Morningstar Value ETFVanguard Intermediate-Term Corporate Bond ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 8, 2023 | 122 | $332.2M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFVanguard Morningstar Value ETF | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 8, 2023 | 115 | $344.8M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFJPMorgan Ultra-Short Income ETF | vs. Q1 2023 | SEC |
| Q1 2023 | May 5, 2023 | 111 | $326.6M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFJPMorgan Ultra-Short Income ETF | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 7, 2023 | 129 | $303.6M | J P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETFVanguard Morningstar Value ETF | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 8, 2022 | 115 | $218.3M | Fidelity MSCI Health Care Index ETFJ P Morgan Exchange Traded FVanguard Intermediate-Term Corporate Bond ETF | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 5, 2022 | 130 | $206.2M | J P Morgan Exchange Traded FFidelity MSCI Health Care Index ETFVanguard Morningstar Value ETF | vs. Q1 2022 | SEC |
| Q1 2022 | May 10, 2022 | 147 | $234.7M | Fidelity MSCI Health Care Index ETFState Street Consumer Discretionary Select Sector SPDR ETFVanguard Morningstar Value ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Apr 15, 2022Amended | 165 | $247.3M | Schwab Fundamental International Equity ETFSPYBBN | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 1, 2021 | 127 | $159.1M | BBNSPYSchwab Fundamental International Equity ETF | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 5, 2021 | 157 | $186.2M | BBNSPYSchwab Fundamental International Equity ETF | vs. Q1 2021 | SEC |
| Q1 2021 | May 7, 2021 | 134 | $162.7M | BBNSPYARK Innovation ETF | – | SEC |